ISOLATED LOCAL RECURRENCE IS RARE AFTER RADICAL PROSTATECTOMY IN MEN WITH GLEASON 7 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS: THERAPEUTIC IMPLICATIONS
Author:
Affiliation:
1. From the Departments of Urology and Pathology, James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference9 articles.
1. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up;Epstein;Am J Surg Pathol,1996
2. Disease progression following radical prostatectomy in men with Gleason score 7 tumor;Epstein;J Urol,1998
3. Biological determinants of cancer progression in men with prostate cancer;Stamey;JAMA,1999
4. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease;Han;J Urol,2000
5. Correlation of pathologic findings with progression after radical retropubic prostatectomy;Epstein;Cancer,1993
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy;Frontiers in Oncology;2021-04-15
2. Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy;Frontiers in Oncology;2019-02-28
3. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy;The Journal of Sexual Medicine;2018-09
4. Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy;Türk Üroloji Dergisi/Turkish Journal of Urology;2015-05-29
5. Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer;Cancer;2010-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3